NEW YORK STOCK EXCHANGE, INC. · QGEN
-2.43% · -$1.09 · Vol 1.4M
Market closed · last close 4:00 PM ET · price as of 19:00:00 ET
Qiagen NV

Qiagen NV

Life Sciences Tools & Services
$43.69
Card
Relationship Map

Follow $QGEN

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $QGEN by email

Veridion Score

BETAMEDIUM CONF · 5 of 6 factors measuredMethodology
Earnings absence reason unknown
QGEN
Qiagen NV
Tue Sep 22 · market closed · Markets closed · resumes Wed 9:30 ET
Upper range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

65/ 100
Veridion Score
Upper range · MEDIUM confidence · 5 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 5 of 6 factors measured · Tue Sep 22 · market closed · Markets closed · resumes Wed 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is QGEN moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading QGEN catalysts
About Qiagen NV
Life Sciences Tools & Services
Listed since
1996
Employees
6K
Country
NL

Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables, with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by Europe, the Middle East, and Africa (33%) and Asia-Pacific (15%).

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$44.43
Day high
$44.47
Day low
$43.62
Previous close
$44.78
52W high
$55.66
-21.51% from high
52W low
$32.63
48% of range
Market cap
$9.2B
P/E
22.10×
EPS
$1.94
Beta
0.64
Shares out
206.5M
Volume
1.4M
0.56× rel vol
Avg volume
2.6M
VWAP
$43.88
Price history computed in-house
1W
+1.84%
1M
+4.57%
3M
+12.20%
1Y
-4.21%
YTD
-2.85%
SMA 50 $42.59 · above
SMA 200 $42.53 · above
52W position 48%

QGEN overview

Veridion Score
65
Registered · 2026-09-22
5 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around QGEN.Congress disclosuresOpen receipt and filing context for QGEN.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading QGEN Form 4 filings
Public disclosures

Congress activity in QGEN

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for QGEN in the cached public ledger.

Federal contracts

QGEN contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for QGEN in this window.
Lobbying spend

QGEN lobbying filings, year to date.

Registered lobbying filings matched to Qiagen NV.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for QGEN in this window.
Loading news for QGEN
Analyst ratings
Sovereign unlock shows live analyst consensus for QGEN.
Options
Sovereign unlock shows live options positioning for QGEN.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.